Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

5.0K
Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
5.0K
Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

2.1K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.1K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

8.6K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Synergistic Effects of Multi-Kinase Inhibition on <i>LRRK2</i>-G2019S and Alpha-Synuclein Pathologies in Models of Parkinson's Disease.

Biomedicines·2026
Same author

Management of moderate and severe ovarian hyperstimulation syndrome: a Canadian Fertility and Andrology Society clinical practice guideline.

Reproductive biomedicine online·2026
Same author

Approaches to frozen embryo transfer: a Canadian Fertility and Andrology Society guideline.

Reproductive biomedicine online·2026
Same author

Safety, Cognitive, and Behavioral Outcomes in Patients with Dementia with Lewy Bodies Treated with Nilotinib.

Journal of clinical medicine·2025
Same author

Resveratrol Attenuates CSF Markers of Neurodegeneration and Neuroinflammation in Individuals with Alzheimer's Disease.

International journal of molecular sciences·2025
Same author

A Novel Small Molecule Enhances Stable Dopamine Delivery to the Brain in Models of Parkinson's Disease.

International journal of molecular sciences·2025

Related Experiment Video

Updated: May 20, 2025

Rapid and Refined CD11b Magnetic Isolation of Primary Microglia with Enhanced Purity and Versatility
07:54

Rapid and Refined CD11b Magnetic Isolation of Primary Microglia with Enhanced Purity and Versatility

Published on: April 13, 2017

9.7K

Modulation of Peripheral Mast Cell and Brain Microglia Axis via Kinase Inhibition.

Xiaoguang Liu1, Michaeline Hebron1, Kaluvu Balaraman2

  • 1Translational Neurotherapeutics Program, Laboratory for Dementia and Parkinsonism, Department of Neurology, Georgetown University Medical Center, Washington, DC 20057, USA.

Metabolites
|March 26, 2025
PubMed
Summary

A new broad kinase inhibitor, BK40196, effectively reduces tau pathology and neuroinflammation in mouse models. This compound shows promise for treating neurodegenerative diseases like tauopathies by targeting mast cells and microglia.

Keywords:
autophagyc-KIT/c-Abl (Abelson) inhibitorinflammationneurodegenerationpTau

More Related Videos

Analyzing the Functions of Mast Cells In Vivo Using 'Mast Cell Knock-in' Mice
09:07

Analyzing the Functions of Mast Cells In Vivo Using 'Mast Cell Knock-in' Mice

Published on: May 27, 2015

10.2K
Author Spotlight: Insights and Innovations in Gene Expression Manipulation Techniques for Choroid Plexus Research
04:43

Author Spotlight: Insights and Innovations in Gene Expression Manipulation Techniques for Choroid Plexus Research

Published on: June 16, 2023

847

Related Experiment Videos

Last Updated: May 20, 2025

Rapid and Refined CD11b Magnetic Isolation of Primary Microglia with Enhanced Purity and Versatility
07:54

Rapid and Refined CD11b Magnetic Isolation of Primary Microglia with Enhanced Purity and Versatility

Published on: April 13, 2017

9.7K
Analyzing the Functions of Mast Cells In Vivo Using 'Mast Cell Knock-in' Mice
09:07

Analyzing the Functions of Mast Cells In Vivo Using 'Mast Cell Knock-in' Mice

Published on: May 27, 2015

10.2K
Author Spotlight: Insights and Innovations in Gene Expression Manipulation Techniques for Choroid Plexus Research
04:43

Author Spotlight: Insights and Innovations in Gene Expression Manipulation Techniques for Choroid Plexus Research

Published on: June 16, 2023

847

Area of Science:

  • Neuroscience
  • Pharmacology
  • Immunology

Background:

  • Kinase inhibition is a key therapeutic strategy for neurodegenerative diseases.
  • Specific kinases like c-KIT, c-Abl, and FYN play roles in neuroinflammation and tau pathology.
  • Existing treatments for neurodegeneration have limitations, necessitating novel therapeutic approaches.

Purpose of the Study:

  • To synthesize and evaluate a novel broad kinase inhibitor, BK40196.
  • To investigate the effects of BK40196 on tau hyper-phosphorylation, cell loss, neuroinflammation, and behavior in mouse models of neurodegeneration.
  • To explore the mechanisms of action of BK40196, including its impact on mast cells and microglia.

Main Methods:

  • Synthesis of the novel broad kinase inhibitor BK40196.
  • Pharmacokinetic and pharmacodynamic studies in transgenic mouse models (rTg4510 and TgAPP).
  • Assessment of behavioral functions, protein levels (hyper-phosphorylated tau), mast cell maturation, and microglial activity in vivo.

Main Results:

  • BK40196 demonstrated high brain penetration and a favorable therapeutic window.
  • BK40196 acts as a dual c-KIT/c-Abl inhibitor with affinity for other kinases (SRC, FYN).
  • BK40196 reduced hyper-phosphorylated tau, attenuated cell loss, improved motor and cognitive functions, and decreased neuroinflammation by inhibiting mast cells and microglia.

Conclusions:

  • BK40196 effectively alleviates neurodegenerative pathology in mouse models.
  • The compound's dual action on peripheral and central immunity via mast cells and microglia, coupled with anti-inflammatory and protein clearance mechanisms, offers synergistic benefits.
  • BK40196 represents a promising therapeutic candidate for human tauopathies and other neurodegenerative conditions.